Quanterix Raises $2.5M, Targeting $5M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Diagnostics firm Quanterix has raised $2.5 million in a financing round targeting $5 million, it disclosed in a document filed with the US Securities and Exchange Commission this week.

The Cambridge, Mass., firm did not say how the funds will be used in its filing, but said it is not in connection with a business combination such as a merger, acquisition, or exchange offer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.